ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Negative correlation between circulating integrin α4+ group 3 innate lymphoid cells and the severity of type 2 diabetes

Zhuang, Yu-Pei; Pan, Zhao-Yu; Huang, Jian-Ming; Zhou, Hong-Guang; Yang, Xiao-Rong*; Zhong, Hao-Jie*广东药学院; 1
International Immunopharmacology2023-6DOI: 10.1016/j.intimp.2023.110237
1被引4阅读
引用收藏
分享

摘要

Background: Impaired intestinal barrier and immune dysfunction promote the development of type 2 diabetes (T2D). Group 3 innate lymphoid cells (ILC3s), which are enriched in the intestinal lamina propria, are key for intestinal barrier integrity. However, there is a paucity of data on circulating ILC3s in patients with T2D. @@@ Purpose: To examine the characteristics of ILC3s in patients with T2D and identify the relationship between ILC3s and clinical indicators of T2D. @@@ Methods: Fifty-nine patients with T2D and thirty controls were enrolled in this retrospective study. Peripheral blood mononuclear cells were isolated and analyzed by flow cytometry and plasma cytokine levels were measured by enzyme-linked immunosorbent assays. @@@ Results: The proportion of circulating ILC3s in the T2D group was significantly lower than that in controls and showed a negative correlation with fasting glucose and glycated hemoglobin and a positive correlation with granulocyte-macrophage colony-stimulating factor (GM-CSF). Similarly, the proportion of circulating integrin alpha 4(+) ILC3s was also significantly lower in the T2D group and showed a negative correlation with fasting glucose and glycated hemoglobin and a positive correlation with GM-CSF. Moreover, the level of circulating integrin alpha 4(+) ILC3s showed a positive correlation with the proportion of circulating dendritic cells (DCs), which was also decreased in patients with T2D and positively associated with GM-CSF. @@@ Conclusion: ILC3s, especially integrin alpha 4(+) ILC3s, were decreased in patients with T2D and showed a negative correlation with disease severity. These cell subsets may delay the progression of T2D by promoting DC differentiation via the secretion of GM-CSF.

学科与关键词

关键词
Clinical indicatorsDendritic cellsGranulocyte-macrophage colony-stimulating factorGroup 3 innate lymphoid cellsType 2 diabetes
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2023-06
卷期
第 119 卷
页码
110237
DOI
10.1016/j.intimp.2023.110237
语言
ENGLISH
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2021M700034]

作者

  • Z

    Zhuang, Yu-Pei (第一作者)

    nanjing univ chinese med · 1 · guangdong pharmaceut univ

  • P

    Pan, Zhao-Yu

    1 · guangdong pharmaceut univ

查看全部 6 位作者收起作者
  • H

    Huang, Jian-Ming

    1 · guangdong pharmaceut univ

  • Z

    Zhou, Hong-Guang

    nanjing univ chinese med

  • Y

    Yang, Xiao-Rong (通讯)

    1 · guangdong pharmaceut univ

  • Z

    Zhong, Hao-Jie (通讯)

    1 · guangdong pharmaceut univ · 2 · shenzhen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417